Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Exact Sciences's peak revenue was $2.8B in 2024. The peak quarterly revenue was $713.4M in 2024(q4).
Exact Sciences's revenue increased from $51.0k in 2001 to $2.8B currently. That's a 5,409,443.14% change in annual revenue.
| Fiscal year / year | Exact Sciences revenue |
|---|---|
| 2009 | $4.8M |
| 2010 | $5.3M |
| 2011 | $4.2M |
| 2012 | $4.1M |
| 2013 | $4.1M |
| 2014 | $1.8M |
| 2015 | $39.4M |
| 2016 | $99.4M |
| 2017 | $266.0M |
| 2018 | $454.5M |
| 2019 | $876.3M |
| 2020 | $1.5B |
| 2021 | $1.8B |
| 2022 | $2.1B |
| 2023 | $2.5B |
| 2024 | $2.8B |
How accurately did Exact Sciences' revenue projections match actual performance?
Exact Sciences saw the greatest revenue growth in 2015, when revenue increased by 2,093.38%.
Exact Sciences had the lowest revenue growth in 2009, when revenue changed by -648.79%.
| Year | Exact Sciences growth |
|---|---|
| 2009 | -649%↓ |
| 2010 | 12%↑ |
| 2011 | -22%↓ |
| 2012 | -0%↓ |
| 2013 | 0%↓ |
| 2014 | -57%↓ |
| 2015 | 2093%↑ |
| 2016 | 152%↑ |
| 2017 | 168%↑ |
| 2018 | 71%↑ |
| 2019 | 93%↑ |
| 2020 | 70%↑ |
| 2021 | 18%↑ |
| 2022 | 18%↑ |
| 2023 | 20%↑ |
| 2024 | 10%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $1.0M | $1.3M | $1.3M | $1.2M |
| 2010 | $1.3M | $1.3M | $1.4M | $1.4M |
| 2011 | $1.0M | $1.0M | $1.0M | $1.0M |
| 2012 | $1.0M | $1.0M | $1.0M | $1.0M |
| 2013 | $1.0M | $1.0M | $1.0M | $1.0M |
| 2014 | $294,000 | - | - | $1.5M |
| 2015 | $4.3M | $8.1M | $12.6M | $14.4M |
| 2016 | $14.8M | $21.2M | $28.1M | $35.2M |
| 2017 | $48.4M | $57.6M | $72.6M | $87.4M |
| 2018 | $90.3M | $102.9M | $118.3M | $143.0M |
| 2019 | $162.0M | $199.9M | $218.8M | $295.6M |
| 2020 | $347.8M | $268.9M | $408.4M | $466.3M |
| 2021 | $402.1M | $434.8M | $456.4M | $473.8M |
| 2022 | $486.6M | $521.6M | $523.1M | $553.0M |
| 2023 | $602.5M | $622.1M | $628.3M | $646.9M |
| 2024 | $637.5M | $699.3M | $708.7M | $713.4M |
Do you work at Exact Sciences?
Did Exact Sciences meet its revenue projections?
| CEO | Kevin T. Conroy |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 4,110 |
| Date Founded | 1995 |
| Headquarters | Madison, Wisconsin |
| Number of Locations | 5 |
| Revenue | $2.8B |
| Net Income | -$623,506,000 |
| Gross Proft | $1.9B (2024) |
| EBITDA | ($728.9M) (2021) |
| PE Ratio | -9.31 |
| Tax Rate | 0.0% |
| Market Capitalization | $9.6B |
| Total Assets | $6,226,873,000 |
| Ticker | EXAS |
Exact Sciences received early financing of $8.2M on 2009-06-15.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $8.2M | 06/2009 |
| Post Ipo Equity | $174M | 07/2015 |
| Post Ipo Debt | $850M | 02/2020 |
| Investors | Security type |
|---|---|
| Excel Venture Management | Post Ipo Equity |
Exact Sciences's top competitor, Walgreens, earned an annual revenue of $147.7B.
Exact Sciences's smallest competitor is PSS with revenue of $25.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 1,729 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 754 |
| Incyte | $103,592 | $4.2B | 1,600 | 40 |
| Regeneron | $85,589 | $14.2B | 9,123 | 368 |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | 1 |
| Baxter International | $54,368 | $10.6B | 48,000 | 202 |
| Seagen | $85,008 | $2.0B | 900 | - |
| Walgreens | $31,612 | - | 210,500 | 20,571 |
| Robert Wood Johnson Foundation | $50,430 | $619.0M | 270 | 2 |
| PSS | $46,526 | $25.0M | 100 | 22 |
Zippia gives an in-depth look into the details of Exact Sciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Exact Sciences. The employee data is based on information from people who have self-reported their past or current employments at Exact Sciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Exact Sciences. The data presented on this page does not represent the view of Exact Sciences and its employees or that of Zippia.
Exact Sciences may also be known as or be related to EXACT SCIENCES CORP, EXACT Sciences Corp., Exact Sciences, Exact Sciences Corp. and Exact Sciences Corporation.